Profound Medical Corp
PROF - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$335.37M
Close$
$-4.77
170.9% downside
Current Fair Value
170.9% downsideOvervalued by 170.9% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $335.37 Million |
|---|---|
| Enterprise Value | $302.13 Million |
| Earnings per Share | $-1.43 |
| Beta | 0.53 |
| Outstanding Shares | 36,350,665 |
Return
| Return on Equity | 164.32% |
|---|---|
| Return on Assets | 131.19% |
| Return on Invested Capital | -49.88% |
Valuation & Multiples
| P/E Ratio | -6.79 |
|---|---|
| PEG | 17.31 |
| Price to Sales | - |
| Price to Book Ratio | 6.73 |
| Enterprise Value to Revenue | 35.47 |
| Enterprise Value to EBIT | -11.37 |
| Enterprise Value to Net Income | 3 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Last Earnings Call
Report Date
October 29, 2026
EPS Estimate
$-0.23
Consensus analyst estimateRevenue Estimate
$6.33 M
Consensus analyst estimateNext Earnings Call
Expected Date
November 5, 2026
EPS Estimate
$-0.19
Consensus analyst estimateRevenue Estimate
$8.82 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 226.30% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.18%▼ 44.01% |
|---|---|
| Total Invested | $380,596▼ 99.64% |
| Investors Holding | 4▼ 57.00% |
About Profound Medical Corp
162 employees
CEO: Arun Swarup Menawat
Profound is a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue. Profound is commercializing TULSA-PRO®, a technology that combines real-time MR...